Dirk Tomsitz (D Tomsitz)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Peritoneal Dialysis

Ejection Fraction

High Resolution

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Dirk Tomsitz, Theresa Ruf, Sarah Zierold, Lars E French, Lucie Heinzerling
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors. Cancers 15 (9) (2023)
Dirk Tomsitz, Theresa Ruf, Markus Vincent Heppt, Ramon Staeger, Egle Ramelyte, Reinhard Dummer, Marlene Garzarolli, Friedegund Meier, Eileen Meier, Heike Richly, Tanja Gromke, Jens Thomas Siveke, Cindy Franklin, Kai-Christian Klespe, Cornelia Mauch, Teresa Kilian, Marlene Seegräber, Bastian Schilling, Lars E French, Carola Berking, Lucie Heinzerling
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study. Cancers 15 (13) (2023)
Dirk Tomsitz, Theresa Ruf, Sarah Zierold, Lars E French, Lucie Heinzerling
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors. Cancers 15 (9) (2023)
Dirk Tomsitz, Max Schlaak, Sarah Zierold, Giulia Pesch, Thomas U Schulz, Genoveva Müller, Christine Zecha, Lars E French, Lucie Heinzerling
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma. Cancers 14 (13) (2022)
Dirk Tomsitz, T Biedermann
Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Dirk Tomsitz, Tilo Biedermann, Knut Brockow
Sublingual immunotherapy reduces reaction threshold in three patients with wheat-dependent exercise-induced anaphylaxis. Allergy 76 (12) (2021)